Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-33643

ABSTRACT: Comparison of gene expression alterations induced by distinct PI3K inhibitors

OTHER RELATED OMICS DATASETS IN: PRJNA148663

PROVIDER: E-GEOD-33643 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-33643-analysis-methods.tsv	Tabular
	E-GEOD-33643-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-33643-configuration.xml	Xml
	E-GEOD-33643-percentile-ranks.tsv	Tabular
	E-GEOD-33643.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 195

Similar Datasets

E-GEOD-56579

Project description:Gene expression profiling upon PI3K inhibition using different inhibitors

2025-01-24 | E-GEOD-56579 | ExpressionAtlas

Homo sapiens

Project description:Comparison of gene expression alterations induced by distinct PI3K inhibitors

| PRJNA148663 | ENA

E-GEOD-18370

Project description:21T series cell lines show distinct stage-specific gene expression alterations

2025-01-24 | E-GEOD-18370 | ExpressionAtlas

E-GEOD-47087

Project description:Gene expression alterations in human colon cancer xenograft treated with anti-VEGF antibody

2025-01-24 | E-GEOD-47087 | ExpressionAtlas

E-GEOD-52354

Project description:Gene expression comparison of E14.5 Foxd1 null and wild type kidneys

2015-07-27 | E-GEOD-52354 | ExpressionAtlas

E-GEOD-52118

Project description:Comparison of gene expression in motor pools with differential vulnerability in ALS

2015-07-27 | E-GEOD-52118 | ExpressionAtlas

E-GEOD-42895

Project description:Loss of MeCP2 function is associated with distinct gene expression changes in the striatum

2015-10-12 | E-GEOD-42895 | ExpressionAtlas

E-GEOD-54931

Project description:Comparison of gene expression pattern between Wild-type and Setd2 knockout mESCs [Affymetrix]

2014-10-28 | E-GEOD-54931 | ExpressionAtlas

Copy number profiling of 92 human lung tumors on Affymetrix 100K SNP arrays

Project description:Copy number profiling of 92 human lung tumors on Affymetrix 100K SNP arrays was conducted in order to assess the interaction of common genomic alterations with response to targeted anti-cancer therapeutics. Class 1 phosphatidylinositol 3' kinase (PI3K) plays a major role in cell proliferation and survival in a wide variety of human cancers. Here we investigate biomarker strategies for PI3K pathway inhibitors in non-small-cell lung cancer (NSCLC). Molecular profiling of NSCLC tumor samples showed that copy number gains in PIK3CA and total loss of PTEN protein were common in squamous cell carcinoma samples, whereas LKB1 loss and mutations in KRAS and EGFR were common in adenocarcinomas. A panel of NSCLC cell lines characterized for alterations in the PI3K pathway was screened with PI3K and dual PI3K/mTOR inhibitors to assess the preclinical predictive value of candidate biomarkers. Cell lines harboring pathway alterations (RTK activation, PI3K mutation or amplification, PTEN loss) were exquisitely sensitive to the PI3K inhibitor GDC-0941. A dual PI3K/mTOR inhibitor had broader activity across the cell line panel and in tumor xenografts. The combination of GDC-0941 with paclitaxel, erlotinib, or a MEK inhibitor had greater effects on cell viability than PI3K inhibition alone. CONCLUSIONS: Candidate biomarkers for PI3K inhibitors have predictive value in preclinical models and show histology-specific alterations in primary tumors, suggesting that distinct biomarker strategies may be required in squamous compared with non-squamous NSCLC patient populations. Lung tumors were profiled on Affymetrix GeneChip Mapping 100K Set Arrays Tumor samples were profiled for copy number without any treatment of the tumor.

2013-01-10 | E-GEOD-39793 | biostudies-arrayexpress

E-GEOD-7179

Project description:Comparison of gene expression data between wild-type and DM1-affected undifferentiated hES cells.

2025-01-24 | E-GEOD-7179 | ExpressionAtlas